Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Aquinox closes $14.5mm Series A financing

Executive Summary

Aquinox Pharmaceuticals Inc. (small-molecule cancer, autoimmune, and inflammation therapeutics) raised $14.5mm through its Series A financing that was led by Ventures West Capital. New investors Johnson & Johnson Development Corp. and Baker Brothers Investments were joined by returning buyer BC Advantage Funds (managed by Lions Capital).

Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies